Data collection
EVENTS, SECONDARY, MAY
The cost analysis captures the total costs of the TRAIN intervention incremental to the existing microcredit programme. Primary and secondary cost data were collected for the period of October 2016−January 2020, which included 6 months of start‐up and 3 years of full implementation. The SEEMS mixed‐methods approach combines financial expenditure data with micro‐costing methods to identify and value resources and allocate costs to activities and inputs. The Activity‐Based‐Costing‐Ingredients (ABC‐I) method (Kaplan & Anderson, We leveraged secondary data from programme monitoring and reports. When available, planning and progress reports were reviewed retrospectively for randomly selected programme staff and frontline workers. Costs were disaggregated into start‐up and recurrent categories. Start‐up costs occurred in the first 6 months, such as planning, materials development and staff training. Recurrent costs included ongoing activities like household visits, community events and monitoring.Primary cost data were collected in two rounds (May 2019 and February 2020) through semistructured in‐depth interviews (IDIs) and focus group discussions (FGDs). IDIs and FGDs gathered data on interviewees' opportunity costs and out‐of‐pocket (OPP) expenses. In the first round of data collection, we organised IDIs and FGDs at a centralised location. FGDs were conducted with FOs (We estimated the opportunity cost of beneficiary participation with data from the process evaluation. The process evaluation included information on beneficiary time use for the index female respondent and the index husband in each household.Data were stored in secure password‐protected computers and servers according to IFPRI and BRAC data governance policies. The data were only accessible to the research team. All hard copies of consent forms, structured interviews and timesheets were kept in a safe location only accessible to the research team. Ethical clearance for the impact evaluation including cost analyses was obtained from the IFPRI Institutional Research Board, BRAC University, Bangladesh, and the Bangladesh Medical Research Council. The study was registered on the Registry for International Development Impact Evaluation.